Covered recipient · General Payments record
JENNIFER DIBERT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$341.78
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.02 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $56.82 | 5 |
| Merck Sharp & Dohme Corporation | $42.43 | 3 |
| SANOFI PASTEUR INC. | $40.55 | 2 |
| Verrica Pharmaceuticals Inc. | $24.63 | 1 |
| Phadia US Inc. | $23.28 | 1 |
| BioMarin Pharmaceutical Inc. | $21.88 | 1 |
| PFIZER INC. | $17.94 | 1 |
| GlaxoSmithKline, LLC. | $16.67 | 1 |
| Exeltis, USA Inc. | $15.42 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | $21.88 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127061182 | CMS |
| Corium, LLC | $16.51 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100108716 | CMS |
| Corium, LLC | $14.95 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100112926 | CMS |
| Corium, LLC | $8.94 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100124896 | CMS |
| Corium, LLC | $0.72 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100138397 | CMS |
| Corium, LLC | $15.70 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100165835 | CMS |
| Exeltis, USA Inc. | $15.42 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011327 | CMS |
| GlaxoSmithKline, LLC. | $16.67 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116413875 | CMS |
| Merck Sharp & Dohme LLC | $14.34 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141908468 | CMS |
| Merck Sharp & Dohme LLC | $13.90 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141970831 | CMS |
| Merck Sharp & Dohme LLC | $14.19 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141828116 | CMS |
| PFIZER INC. | $17.94 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131509388 | CMS |
| Phadia US Inc. | $23.28 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067580150 | CMS |
| SANOFI PASTEUR INC. | $20.85 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128751733 | CMS |
| SANOFI PASTEUR INC. | $19.70 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128751735 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.40 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147857773 | CMS |
| Verrica Pharmaceuticals Inc. | $24.63 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118390908 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.